Sensus (SRTS): Enterprise Value to EBITDA Ratio

Sensus Healthcare, Inc. (SRTS) outsources its electronics production, while the current stock quotes displayed on GURU.Markets reflect an EV/EBITDA of 0.00. A team of engineers and physicians develops innovative dermatology systems, leveraging high staff loyalty. Patents and FDA certification, combined with a broad clinical presence, create significant barriers to entry for competitors.
Comprehensive metric breakdowns and analytics for sensushealthcare.com (SRTS)

This indicator compares the total enterprise value, including net debt, with earnings before interest, taxes, depreciation, and amortization, determining the real value of assets relative to their ability to generate cash flow. For Sensus Healthcare, Inc. (SRTS), which possesses pricing power in the radiation therapy niche, the EV/EBITDA ratio trend allows for an assessment of whether the market price is justified by current returns amid limited client budgets.